Vasculitis: A dialogue between the artery and the immune system

Inflammatory Diseases of Blood Vessels

Volumn , Issue , 2016, Pages 1-12

  Weyand, Cornelia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037618311     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (35)

1. Cines DB, Pollak US, Buck CA, Loscalza J, Zimnierma n GA.Mc Ever RR Pober JS, Wick TM, Kon-kit BA, Schwartz B5, Bamathan ES, McCrae KR, Hug BA, Schmidt AM, Stem DM, Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood 1998:91:3527-3561.
2. Kri shnaswamy G, Kel ley J, Vcrra L Smith JK, Chi DS, Human cndol hcli u m as a source of multifunctional cytokines: molecular regulation and possible role in human disease, J Interferon Cytokine Res 1999:19:91-103
3. Butther EC Picker U, Lymphocyte homing and homeostasis, Science 1996:272:60-66.
4. Wang J, Springer TA, Structural specialization of imrmi noglobul in superfamily mc tnocrs lor adhesion to irlleririns and vimnes, Immunol Rev 1998:163:197-215.
5. Andres V, Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis (review), Int J Mai Med 1998; 2:81-89
6. Wilcox JN, Scott NA, Potential role of the adventitia in arteritis and atherosclerosis, Int J Cardiol l996: 54(suppl}:S21-S35.
7. Wagner AD, Bjornsson J, Bartley GB, Goronzy 11, Weyand CM, Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology, Am J Pathol 1996; 148: 1925-1933.
8. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DRJ, Schwartz RS, Lerman A, Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia, J Clin Invest 1998; 101:1551-1556.
9. Coats WD, Jr., Faxon DP, The role of the extracellular matrix in arterial remodelling, Semin Interv Cardio11997; 2:167-176.
10. Ruoslahti E, Engvall E, Integrins and vascular extracellular matrix assembly, J Clin Invest 1997; 100: S53-S56.
11. Ruoslahti E, Vaheri A, Cell-to-cell contact and extracellular matrix, Curr Opin Cell BioI 1997; 9:605607.
12. Hynes RO, Wagner DD, Genetic manipulation of vascular adhesion molecules in mice, J Clin Invest 1997; 100:S11-3.
13. Garlanda C, Dejana E, Heterogeneity of endothelial cells, Specific markers, Arterioscler Thromb Vasc BioI 1997; 17:1193-1202.
14. Shanahan CM, Weissberg PL, Smooth muscle cell heterogeneity: Patterns of gene expression in vascular smooth muscle cells in vitro and in vivo, Arterioscler Thromb Vasc BioI 1998; 18:333-338.
15. Butcher EC, Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity, Cell 1991; 67:1033-1036.
16. Pasqualini R, Ruoslahti E, Organ targeting in vivo using phage display peptide libraries, Nature 1996; 380:364-366.
17. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E, Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display, J Clin Invest 1998; 102:430-437.
18. Kwon HM, Sangiorgi G, Ritman EL, Lerman A, McKenna C, Virmani R, Edwards WD, Holmes DR, Schwartz RS, Adventitial vasa vasorum in balloon-injured coronary arteries: Visualization and quantitation by a microscopic three-dimensional computed tomography technique, JAm Coli Cardiol 1998; 32:2072-2079.
19. Archer SL, Diversity of phenotype and function of vascular smooth muscle cells, J Lab Clin Med 1996; 127:524-529.
20. Majesky MW, Schwartz SM, An origin for smooth muscle cells from endothelium? Circ Res 1997; 80:601-603.
21. Weyand CM, Goronzy JJ, Giant cell arteritis as an antigen-driven disease, Rheum Dis Clin North Am 1995; 21:1027-1039.
22. Ross R, Atherosclerosis-An inflammatory disease, N Engl J Med 1999; 340: 115-126.
23. Weyand CM, Wagner AD, Bjornsson J, Goronzy 11, Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis, J Clin Invest 1996; 98:1642-1649.
24. Martinez-Taboada V, Brack A, Hunder GG, Goronzy 11, Weyand CM, The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes, J Rheumatol 1996; 23:1011-1014.
25. Lie JT, Illustrated histopathologic classification criteria for selected vasculitis syndromes, American College of Rheumatology Subcommittee on Classification of Vasculitis, Arthritis Rheum 1990; 33: 1074-1087.
26. Weyand CM, TetzlaffN, Bjornsson J, Brack A, Younge B, Goronzy 11, Disease patterns and tissue cytokine profiles in giant cell arteritis, Arthritis Rheum 1997; 40: 19-26.
27. Nikkari ST, Hoyhtya M, Isola J, Nikkari T, Macrophages contain 92-kD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis, Am J Pathol 1996; 149: 1427-1433.
28. Kaiser M, Weyand CM, Bjornsson J, Goronzy 11, Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis, Arthritis Rheum 1998; 41 :623-633.
29. Kaiser M, Younge B, Bjornsson J, Weyand CM, Goronzy 11, Formation of new vasa vasorum in vasculitis: Production of angiogenic cytokines by multinucleated giant cells, Am J Pathol 1999; in press.
30. Quaranta V, Plopper GE, Integrins and laminins in tissue remodeling, Kidney Int 1997; 51: 1441-1446, Faxon DP, Coats W, Currier J, Remodeling of the coronary artery after vascular injury, Prog Cardiovasc Dis 1997; 40:129-140.
31. Faxon DP, Coats W, Currier J, Remodeling of the coronary artery after vascular injury, Prog Cardiovasc Dis 1997; 40:129-140
32. Alpers CE, Davis CL, Barr D, Marsh CL, Hudkins KL, Identification of platelet-derived growth factor A and B chains in human renal vascular rejection, Am J Pathol 1996; 148:439-451.
33. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM, Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis, J Clin Invest 1999; 103: 10071013.
34. Bohren KM, Bullock B, Wermuth B, Gabbay KH, The aldo-keto reductase superfamily, cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases, J Bioi Chern 1989; 264: 9547-9551.
35. Flynn TG, Green NC, The aldo-keto reductases: An overview, Adv Exp Med BioI 1993; 328:251-257.